Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-24 @ 3:51 PM
NCT ID:
NCT02182492
Eligibility Criteria:
Inclusion Criteria:
* Meeting the CRS diagnostic criteria including CRSsNP and CRSwNP based on the EP3OS definition
* Age ≥16 and ≤70 years
* Chinese of either sex
* Failure to conventional medical therapies according to EP3OS recommendation
Exclusion Criteria:
* Pregnant or breast-feeding women
* Cystic fibrosis
* Congenital ciliary dyskinesia
* Sinonasal fungal disease
* Systemic vasculitis
* Granulomatous disease
* Tumor
* Immunodeficiency
* Allergic to clarithromycin or topical corticosteroid
* With an upper respiratory tract infection within 4 weeks of entering the study
* With serious metabolic, cardiovascular, autoimmune, neurology, blood, digestive, cerebrovascular, respiratory system disease, or any disease interfering with the evaluation of results or affecting subjects' safety such as glaucoma and tuberculosis
* With emotional or mental problems
* Have received immunotherapy within the previous 3 months
* Have had a history of local or systemic medications, such as glucocorticoids and macrolides within 4 weeks
* Have had an acute asthmatic within the 4 weeks before entering the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
70 Years
Study:
NCT02182492
Study Brief:
Protocol Section:
NCT02182492